ELA

Envela Corporation

47
Fundamentals84/ 100
Valuation48/ 100
Upside potential32/ 100
Risk potential42/ 100

ELA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.

NIO

NIO Inc.

56
Fundamentals77/ 100
Valuation50/ 100
Upside potential58/ 100
Risk potential27/ 100

NIO has the edge over ELA overall, supported by stronger modeled upside and lower modeled downside.

ELA Fundamentals

MetricStatus
Strong
Strong
Healthy
Strong

ELA's revenue, profitability, cash flow and balance sheet are all currently healthy.

NIO Fundamentals

MetricStatus
Strong
Stable
Stable
Unavailable

NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.

ELA PE Valuation

CHEAPFAIREXPENSIVE11x22x32x43x
CHEAPFAIREXPENSIVE11x22x32x43x
LevelPEPriceVs current
Cheap12x$10.14-2.4%
Current12x$10.39—
Fair18x$15.50+49%
Forward19x$10.39—
Expensive30x$25.09+141%

Historical ranges are pointers, not guarantees.

ELA's PE is in its cheap range at 12x. Analysts expect earnings to fall, which would put today's price at 19x next year's earnings, in its fair range.

NIO PE Valuation

NIO has no meaningful PE right now: it lost money over the past year.

ELA Forward outlook

MetricOutlook
Strongly deteriorating
Strong decline
Decline
Weakening
Limited
Moderate

Analysts expect ELA's earnings and revenue to decline, with profitability weakening.

NIO Forward outlook

MetricOutlook
--
Losses shrinking
Growth
Strongly improving
Limited
Moderate

NIO has the edge over ELA on the outlook, with more favorable earnings and revenue expectations.

ELA Risk to reward

ScenarioChangePrice
Upside+20%$12.49
Downside-42%$5.98

Calculated from the latest close: $10.39 on Nov 12.

ELA trails NIO on modeled risk to reward, with less potential upside and more potential downside.

NIO Risk to reward

ScenarioChangePrice
Upside+38%$4.21
Downside-27%$2.22

Calculated from the latest close: $3.05 on Nov 12.

NIO has a better modeled risk to reward balance than ELA, with more potential upside and less potential downside.

ELA Earnings Per Share

Q3 2023: $0.43Q4 2023: $0.27Q1 2024: $0.25Q2 2024: $0.25Q3 2024: $0.25Q4 2024: $0.26Q1 2025: $0.29Q2 2025: $0.34Q3 2025: $0.41Q4 2025: $0.56Q1 2026: $0.80Q2 2026: $0.85Forward: $0.56
Q3 2023: $0.43Q4 2023: $0.27Q1 2024: $0.25Q2 2024: $0.25Q3 2024: $0.25Q4 2024: $0.26Q1 2025: $0.29Q2 2025: $0.34Q3 2025: $0.41Q4 2025: $0.56Q1 2026: $0.80Q2 2026: $0.85Forward: $0.56
QuarterTTM EPSYoY
Forward$0.56-35%
Q2 2026$0.85+150%
Q1 2026$0.80+176%
Q4 2025$0.56+115%
Q3 2025$0.41+64%
Q2 2025$0.34+36%
Q1 2025$0.29+16%
Q4 2024$0.26-3.7%
Q3 2024$0.25-42%

ELA has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.

NIO Earnings Per Share

Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
QuarterTTM EPSYoY
Q2 2026-$0.29+$1.45
Q1 2026-$0.60+$1.16
Q4 2025-$1.06+$0.60
Q3 2025-$1.59+$0.02
Q2 2025-$1.74-$0.10
Q1 2025-$1.76+$0.06
Q4 2024-$1.66+$0.21
Q3 2024-$1.61+$0.32

NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.

ELA Quarterly Revenue

Q3 2023: $36MQ4 2023: $37MQ1 2024: $40MQ2 2024: $45MQ3 2024: $47MQ4 2024: $48MQ1 2025: $48MQ2 2025: $55MQ3 2025: $57MQ4 2025: $80MQ1 2026: $98MQ2 2026: $57M
Q3 2023: $36MQ4 2023: $37MQ1 2024: $40MQ2 2024: $45MQ3 2024: $47MQ4 2024: $48MQ1 2025: $48MQ2 2025: $55MQ3 2025: $57MQ4 2025: $80MQ1 2026: $98MQ2 2026: $57M
QuarterRevenueYoY
Q2 2026$56.8M+3.5%
Q1 2026$98.4M+104%
Q4 2025$80.5M+67%
Q3 2025$57.4M+22%
Q2 2025$54.9M+21%
Q1 2025$48.3M+21%
Q4 2024$48.3M+32%
Q3 2024$46.9M+29%

ELA has the edge over NIO on sales, with more consistent year-over-year improvement.

NIO Quarterly Revenue

Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
QuarterRevenueYoY
Q2 2026$4.8B+69%
Q1 2026$3.8B+112%
Q4 2025$5.2B+76%
Q3 2025$3.3B+17%
Q2 2025$2.9B+9%
Q1 2025$1.8B+21%
Q4 2024$3B+15%
Q3 2024$2.8B-2.1%

NIO's revenue has grown year over year for seven quarters in a row: $4.8B last quarter, up 69% from the same quarter a year ago.

ELA Free Cash Flow

Q3 2023: $536,828Q4 2023: $2MQ1 2024: $3MQ2 2024: −$1MQ3 2024: $1MQ4 2024: $3MQ1 2025: $746,613Q2 2025: $2MQ3 2025: $2MQ4 2025: −$4MQ1 2026: $21MQ2 2026: $5M
Q3 2023: $536,828Q4 2023: $2MQ1 2024: $3MQ2 2024: −$1MQ3 2024: $1MQ4 2024: $3MQ1 2025: $746,613Q2 2025: $2MQ3 2025: $2MQ4 2025: −$4MQ1 2026: $21MQ2 2026: $5M
QuarterFree cash flowYoY
Q2 2026$5M+137%
Q1 2026$20.6M+2658%
Q4 2025-$3.7M-215%
Q3 2025$2.2M+51%
Q2 2025$2.1M+$3.4M
Q1 2025$746.6K-78%
Q4 2024$3.2M+91%
Q3 2024$1.5M+172%

ELA has the edge over NIO on cash flow, with more consistent year-over-year improvement.

NIO Free Cash Flow

Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: −$2.2BQ3 2024: $0Q4 2024: −$391MQ1 2025: $0Q2 2025: −$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: −$2.2BQ3 2024: $0Q4 2024: −$391MQ1 2025: $0Q2 2025: −$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
QuarterFree cash flowYoY
Q2 2026$0+$2.1B
Q1 2026$0$0
Q4 2025$0+$391.3M
Q3 2025$0$0
Q2 2025-$2.1B+$73.9M
Q1 2025$0$0
Q4 2024-$391.3M-386%
Q2 2024-$2.2B+$337.9M

NIO's free cash flow was $0 over the past year, against −$2.5B the year before.

ELA Total Shares

Q3 2023: 27MQ4 2023: 27MQ1 2024: 26MQ2 2024: 26MQ3 2024: 26MQ4 2024: 26MQ1 2025: 26MQ2 2025: 26MQ3 2025: 26MQ4 2025: 26MQ1 2026: 26MQ2 2026: 26M
Q3 2023: 27MQ4 2023: 27MQ1 2024: 26MQ2 2024: 26MQ3 2024: 26MQ4 2024: 26MQ1 2025: 26MQ2 2025: 26MQ3 2025: 26MQ4 2025: 26MQ1 2026: 26MQ2 2026: 26M
PeriodChange %Net change
Quarterly0%--
1 year-0.1%-28.5K shares
3 years-3.6%-968K shares
5 years-3.6%-976K shares
Available history-3.6%-961K shares

ELA has the edge over NIO on shareholder dilution, with a more favorable share count trend.

NIO Total Shares

Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
PeriodChange %Net change
Quarterly+0.6%+15.6M shares
1 year+12%+267M shares
3 years+51%+844M shares
5 years+60%+933M shares
Available history+143%+1.5B shares

NIO has 2.5B diluted shares, up 12% from a year ago.

ELA Net Leverage

Q3 2023: -0.2xQ4 2023: -0.3xQ1 2024: -0.6xQ2 2024: -0.3xQ3 2024: -0.4xQ4 2024: -0.7xQ1 2025: -0.7xQ2 2025: -0.8xQ3 2025: -0.8xQ4 2025: -0.4xQ1 2026: -1.0xQ2 2026: -1.1x
Q3 2023: -0.2xQ4 2023: -0.3xQ1 2024: -0.6xQ2 2024: -0.3xQ3 2024: -0.4xQ4 2024: -0.7xQ1 2025: -0.7xQ2 2025: -0.8xQ3 2025: -0.8xQ4 2025: -0.4xQ1 2026: -1.0xQ2 2026: -1.1x
QuarterNet LeverageStatus
Q2 2026-1.1xNet Cash
Q1 2026-1.0xNet Cash
Q4 2025-0.4xNet Cash
Q3 2025-0.8xNet Cash
Q2 2025-0.8xNet Cash
Q1 2025-0.7xNet Cash
Q4 2024-0.7xNet Cash
Q3 2024-0.4xNet Cash

ELA has more cash than debt.

NIO Net Leverage

NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

ELA Weekly Momentum

MetricValueStatus
RSI29.8Oversold
Stochastic1.6Oversold

ELA's weekly RSI is 30 (oversold) and its Stochastic is 2 (oversold).

NIO Weekly Momentum

MetricValueStatus
RSI30.7Neutral
Stochastic6.9Oversold

NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).

ELA PE vs Consumer Cyclical Sector

MetricELASector medianRelative
PE12x18x32% below
PE %204727 pts below

ELA is trading at 12x earnings, a 32% discount to the Consumer Cyclical sector's median of 18x.

NIO PE vs Consumer Cyclical Sector

NIO has no meaningful PE right now: it lost money over the past year.

ELA Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$11.510% below
20 week MA$15.332% below
50 week MA$16.637% below
100 week MA$11.812% below
200 week MA$8.6420% above

ELA has the edge over NIO on trend strength, trading above more of its moving averages.

NIO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.369.2% below
20 week MA$4.0124% below
50 week MA$4.8137% below
100 week MA$4.8537% below
200 week MA$6.0349% below

NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.

ELA Yearly ROI

YearStart priceEnd priceROI
2020$1.37$5.01+266%
2021$5.01$4.10-18%
2022$4.10$5.29+29%
2023$5.29$4.86-8.1%
2024$4.86$7.15+47%
2025$7.15$12.5+75%
2026 YTD$12.5$10.4-17%

ELA has the edge over NIO on returns for 2026, with the stronger performance.

NIO Yearly ROI

YearStart priceEnd priceROI
2020$2.42$45.8+1791%
2021$45.8$30.5-33%
2022$30.5$11.0-64%
2023$11.0$9.07-17%
2024$9.07$4.48-51%
2025$4.48$5.10+14%
2026 YTD$5.10$3.05-40%

NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.

Give your agent the market.

Get API key